Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study
Erythroferrone (ERFE) is a hepcidin inhibitor whose synthesis is stimulated by erythropoietin, which increases iron absorption and mobilization. We studied the association between serum ERFE and mortality and non-fatal cardiovascular (CV) events in a cohort of 1123 hemodialysis patients and in a coh...
Main Authors: | Belinda Spoto, Rahul Kakkar, Larry Lo, Matt Devalaraja, Patrizia Pizzini, Claudia Torino, Daniela Leonardis, Sebastiano Cutrupi, Giovanni Tripepi, Francesca Mallamaci, Carmine Zoccali |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/4/523 |
Similar Items
-
Erythroferron: Modern Concepts of Its Role in Iron Metabolism Regulation
by: VT Sakhin, et al.
Published: (2017-01-01) -
The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry
by: Melanie Castro-Mollo, et al.
Published: (2021-05-01) -
Expression of fluorescent tagged recombinant erythroferrone protein
by: Min Min Than, et al.
Published: (2018-01-01) -
Vitamin D and methylarginines in chronic kidney disease (CKD).
by: Claudia Torino, et al.
Published: (2017-01-01) -
Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics
by: Katarzyna Skrypnik, et al.
Published: (2020-04-01)